SCHEMBL24208293

SCHEMBL24208293

C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(S(=O)(=O)O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 10/20 0.76
▸ NR1H4 Q96RI1 4/20 0.76
▸ TDP1 Q9NUW8 3/20 0.76
▸ MEN1 O00255 2/20 0.76
▸ KMT2A Q03164 2/20 0.76
▸ ABCB11 O95342 2/20 0.76
▸ SLC10A2 Q12908 2/20 0.76
▸ LMNA P02545 2/20 0.76
▸ CYP3A4 P08684 2/20 0.76
▸ CYP2C19 P33261 1/20 0.76
▸ CHRM2 P08172 1/20 0.76
▸ ADRA2A P08913 1/20 0.76
▸ ADRA1A P35348 1/20 0.76
▸ ENPP2 Q13822 1/20 0.76
▸ SLC10A1 Q14973 1/20 0.76
▸ CISD1 Q9NZ45 1/20 0.76
▸ CASP7 P55210 3/20 0.68
▸ TP53 P04637 2/20 0.68
▸ MAPK1 P28482 2/20 0.68
▸ HSD17B10 Q99714 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079152 1.00 GPBAR1 (0.76) GPBAR1NR1H4TDP1MEN1KMT2A
SCHEMBL22079169 1.00 GPBAR1 (0.76) GPBAR1NR1H4TDP1MEN1KMT2A
SCHEMBL22034321 1.00 GPBAR1 (0.76) GPBAR1NR1H4TDP1MEN1KMT2A
SCHEMBL22034324 1.00 GPBAR1 (0.76) GPBAR1NR1H4TDP1MEN1KMT2A
SCHEMBL22079146 0.91 GPBAR1 (0.75) GPBAR1NR1H4TDP1MEN1KMT2A
SCHEMBL24208294 0.91 GPBAR1 (0.75) GPBAR1NR1H4TDP1MEN1KMT2A
Chenodiol SCHEMBL29373285 0.89 GPBAR1 (0.92) GPBAR1NR1H4TDP1MEN1KMT2A
Chenodiol SCHEMBL61536 0.88 GPBAR1 (0.98) GPBAR1NR1H4TDP1MEN1KMT2A
Ursodiol SCHEMBL2547966 0.88 GPBAR1 (0.98) GPBAR1NR1H4TDP1MEN1KMT2A
Ursodiol SCHEMBL8829737 0.88 GPBAR1 (0.98) GPBAR1NR1H4TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220016138-A1 SYNTHETIC DERIVATIVES OF CHOLIC ACID 7-SULFATE AND USES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2022-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220016138-A1 SYNTHETIC DERIVATIVES OF CHOLIC ACID 7-SULFATE AND USES THEREOF CYP7A1, NR1H4, CYP7B1 GPBAR1 31/4885NR1H4 2/4885TDP1 3877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback